HIV mutation literature information.


  The Evolving Genotypic Profile of HIV-1 Mutations Related to Antiretroviral Treatment in the North Region of Brazil.
 PMID: 26543866       2015       BioMed research international
Result: The M41L, D67N, V118I, L210W, K219Q, and T69D mutations were more prevalent in experienced patients.
Result: The most prevalent mutations related to NRTIs were M184V (80.1%), followed by M41L (31.8%), T215Y (30.2%), D67N (25.5%), K70R (24.4%), T215F (18.3%), L210W (15.1%), and V118I (15.1%) (Figure 1(a)).


  HIV Drug Resistance Surveillance in Honduras after a Decade of Widespread Antiretroviral Therapy.
 PMID: 26558396       2015       PloS one
Table: V118I


  HIV-1 drug mutations in children from northern Tanzania.
 PMID: 24729604       2014       The Journal of antimicrobial chemotherapy
Table: V118I


  Cobicistat-boosted darunavir in HIV-1-infected adults: week 48 results of a Phase IIIb, open-label single-arm trial.
 PMID: 25926858       2014       AIDS research and therapy
Result: N[t]RTI RAMs were found in 14% of patients (43/313; 36 and seven patients), most commonly V118I (6%; 18/313; 18 and zero patients), T69D/N (3%; 8/313; eight and zero patients) and M184V/I (3%; 8/313; two and six patients).


  Horizontal gene transfer from human host to HIV-1 reverse transcriptase confers drug resistance and partly compensates for replication deficits.
 PMID: 24889250       2014       Virology
Abstract: Concurrently, the NRTI mutations T69I and V118I and the NNRTI mutations K103N and Y181C were detected for the first time.


  2014 Update of the drug resistance mutations in HIV-1.
 PMID: 25101529       2014       Topics in antiviral medicine
Discussion: Although reverse transcriptase changes associated with the E44D and V118I mutations may have an accessory role in increased resistance to nRTIs in the presence of TAMs, their clinical relevance is very limited.


  Persistence of frequently transmitted drug-resistant HIV-1 variants can be explained by high viral replication capacity.
 PMID: 25575025       2014       Retrovirology
Table: V118I


  Early clinical response and presence of viral resistant minority variants: a proof of concept study.
 PMID: 25397504       2014       Journal of the International AIDS Society
Abstract: Single mutations E138K (two cases) and M184V in three distinct patients and V90I+G190E; M184V+A98S; Y215F+V118I+T215I; L210S+T215I+F227L; and A62V+D67G+K70N+188H in the remaining five subjects.


  Transmission patterns of HIV-subtypes A/AE versus B: inferring risk-behavior trends and treatment-efficacy limitations from viral genotypic data obtained prior to and during antiretroviral therapy.
 PMID: 23469241       2013       PloS one
Table: V118I


  Subtype-specific differences in the development of accessory mutations associated with high-level resistance to HIV-1 nucleoside reverse transcriptase inhibitors.
 PMID: 23386260       2013       The Journal of antimicrobial chemotherapy
Abstract: Codon changes K43E, E44D and V118I were found to have no effect on susceptibility to three NRTIs with or without TAMs in either subtype; however, some accessory mutations had subtype-specific effects on viral infectivity.



Browser Board

 Co-occurred Entities




   Filtrator